Studies indicate that cold exposure slightly increases calorie expenditure as the body works harder to maintain core temperature.

Gurugram's Shivani Yadav found holistic success in weight management at Patanjali Wellness Haridwar. Under expert guidance, ...

At 54, Jeev Milkha Singh continues to compete on the Legends Tour, driven by discipline, legacy and one final target - ...

Bengaluru teen Krishna Keshav, battling weight gain and fatty liver, found lasting relief at Patanjali Wellness Centre. A ...

Have you ever tried yoga asanas and poses to boost immunity and fight common winter illnesses like cold, cough, and fever?

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

Losing weight has officially become more convenient. The popular GLP-1 obesity treatment Wegovy is now available as a once-daily pill. On Monday evening, the Food and Drug Administration approved Novo ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the FDA for approval on Thursday. Eli Lilly’s LLY drug is called orforglipron.